CIBC Private Wealth Group
ANIX icon

CIBC Private Wealth Group’s Anixa Biosciences ANIX Stock Holding History

CIBC Private Wealth Group’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$86.9K Buy
27,865
+12,265
+79% +$50.2K ﹤0.01% 1583
2025
Q3 		$51.5K Buy
15,600
+1,000
+7% +$3.16K ﹤0.01% 1784
2025
Q2 		$48.2K Buy
+14,600
New +$41.7K ﹤0.01% 1678

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CIBC Private Wealth Group's ANIX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Anixa Biosciences (ANIX) stake by 79% in Q4 2025, buying an estimated $50.2K and bringing the position to 27,865 shares worth $86.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

CIBC Private Wealth Group first reported a position in ANIX in Q2 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold ANIX as of Q4 2025.

  • CIBC Private Wealth Group held 27,865 shares of Anixa Biosciences worth $86.9K as of Q4 2025.
  • CIBC Private Wealth Group bought 12,265 Anixa Biosciences shares in Q4 2025, an estimated $50.2K.
  • Anixa Biosciences made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1583 holding.
  • CIBC Private Wealth Group first reported a position in Anixa Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.